Nathalie Nagy
Overview
Explore the profile of Nathalie Nagy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rusu S, Nuyens V, Rousseau A, Lothaire P, Nagy N, Boudjeltia K, et al.
Histol Histopathol
. 2024 Dec;
:18858.
PMID: 39711247
Due to the late-stage diagnosis of head and neck squamous cell carcinoma (HNSCC), treatment remains a significant clinical challenge. The metalloproteinases MMP-9 and MT1-MMP play a pivotal role in extracellular...
2.
Tota V, Dagonnier M, Wery D, Binet L, Nagy N, Durieux V, et al.
Lung Cancer
. 2021 Aug;
160:59-65.
PMID: 34411840
Immune checkpoint inhibitors (ICI) improve the prognosis of patients with advanced non-small cell lung cancer. However, clinicians should be aware of potentially life-threatening immune-related adverse events (irAEs). We report a...
3.
Steffens Y, Mat Q, Beatse V, Meert N, Nagy N, Ait Ichou J, et al.
Ear Nose Throat J
. 2020 Sep;
101(6):NP263-NP265.
PMID: 32970480
We describe the first case of ethmoid metastasis from an oropharyngeal human papillomavirus-induced squamous cell carcinoma using the anti-P16 immunohistochemistry. The p16 overexpression can be a valuable aid in the...
4.
Nagy N, Remmelink M, van Vooren J, Salmon I
Acta Endoscopica
. 2020 Mar;
32(2):195-210.
PMID: 32214582
The gastrointestinal tract is frequently involved in immunocompromised hosts. The most common digestive manifestations are dysphagia, odynophagia and diarrhea. These diseases are more frequent in patients with acquired immunodeficiency virus...
5.
DHaene N, Fontanges Q, De Neve N, Blanchard O, Melendez B, Delos M, et al.
Oncotarget
. 2018 May;
9(29):20761-20768.
PMID: 29755687
International guidelines made RAS (KRAS and NRAS) status a prerequisite for the use of anti-EGFR agents for metastatic colorectal cancer (CRC) patients. Daily, new data emerges on the theranostic and...
6.
Bienfait L, Nagy N, El Moussaoui I, Lingier P, El Nakadi I, Demetter P, et al.
Histopathology
. 2018 Feb;
73(1):173-174.
PMID: 29415331
No abstract available.
7.
Dequanter D, Lammens M, Nagy N, Shahla M, Deniz Y, Aubert C, et al.
Med Devices (Auckl)
. 2016 Jun;
9:139-42.
PMID: 27354833
Background: The goal of the study was to determinate the safety of the harmonic scalpel, widely used in thyroidectomy, near the recurrent laryngeal nerve (RLN). Methods: The study involved ten...
8.
Dequanter D, Van de Velde M, Bar I, Nuyens V, Rousseau A, Nagy N, et al.
Oncol Lett
. 2016 Jun;
11(6):3660-3668.
PMID: 27284370
Glutathione (GSH) is the keystone of the cellular response toward oxidative stress. Elevated GSH content correlates with increased resistance to chemotherapy and radiotherapy of head and neck (HN) tumors. The...
9.
Dequanter D, Van de Velde M, Nuyens V, Nagy N, Van Antwerpen P, Vanhamme L, et al.
Eur J Cancer Prev
. 2013 Mar;
22(6):558-60.
PMID: 23492956
Over 90% of head and neck cancers are squamous cell carcinomas (HNSCC) and the overall 5-year survival rate is up to 50%. The redox status of these cancers is an...
10.
De Moor V, Arvanitakis M, Nagy N, Coppens E, Delhaye M, Closset J
Hepatogastroenterology
. 2012 Feb;
59(114):565-9.
PMID: 22353525
Background/aims: To investigate the clinicopathological features of intraductal papillary mucinous neoplasms and evaluate the prognosis between histopathological groups. Methodology: Retrospective review of 55 consecutive patients operated between 1991 and 2006,...